A 13-month multicenter clinical experience of a low-dose monophasic oral contraceptive containing 20 microg ethinylestradiol and 75 microg gestodene in Latin American women.
Bassol S, Alvarado G, Arreola RG, Celis-Gonzalez C, Peña EP, Flores JG, Ahued JR, Ricalde RL, Lopez CR, Prieto G, Gurucharri C, Heredia MG, Ortiz OC, Percossi G, Figueroa Casas PR, Botto E, Tozzini RI, Botti G, Nuñez de Pierro A, Fernandez M, Lastreto E, Nañez M, Carneiro de Oliveira H, Diogenes Holanda Yazlle ME, Silva J, Salazar G, Gomez J, Penagos G, Cifuentes R, Torres LA, Reyes-Marquez R, Albrecht G.
Bassol S, et al. Among authors: nunez de pierro a.
Contraception. 2003 May;67(5):367-72. doi: 10.1016/s0010-7824(02)00483-3.
Contraception. 2003.
PMID: 12742559